63.70 USD
↗ 0.05 (0.08%)AT CLOSE (03:59 PM EDT)
PTC Therapeutics, Inc.
PTCTNASDAQ • USD
63.67
↘ 0.04 (0.05%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
63.67
↘ 0.04 (0.05%)
Market: OPEN
Shares of PTC Therapeutics, Inc. (PTCT) are trading at $63.67. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (23.2%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. PTCT is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Oct 5, 2026.
Open?$64.53
High?$65.27
Low?$62.92
Prev. Close?$63.65
Volume?1.3M
Avg. Volume?1.1M
VWAP?$63.84
Rel. Volume?1.13x
Bid / Ask
Bid?$39.54 × 100
Ask?$85.50 × 100
Spread?$45.96
Midpoint?$62.52
Valuation & Ratios
Market Cap?5.3B
Shares Out?83.5M
Float?78.8M
Float %?95.0%
P/E Ratio?N/A
P/B Ratio?-32.12
EPS?-$0.46
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Themes
Address
500 WARREN CORPORATE CENTER DRIVE
WARREN, NJ 07059
Phone: (908) 222-7000
WARREN, NJ 07059
Phone: (908) 222-7000
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?8
Momentum?85
Short Sent.?48
Piotroski F-Score?4/9Mixed
Altman Z-Score?0.81Distress
Confidence?57%Low
Short InterestVery High
Short % of Float?12.36%High
Short Interest?9.7M
Days to Cover?11.0
Free Float78.8M
Avg Daily Volume882.8K
Settlement Date2026-09-15
Financial Health
Current Ratio?3.39Strong
Quick Ratio?3.28Strong
Cash Ratio?1.36Strong
Debt/Equity?-3.61Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-32.12CHEAP▾
S&P97
P/S?5.27FAIR▾
Peers100
S&P27
P/FCF?N/A▾
EV/EBITDA?28.1HIGH▾
Peers100
S&P12
EV/Sales?4.82FAIR▾
Peers100
S&P37
Returns & Efficiency
ROE?23.2%STRONG▾
Peers50
S&P72
ROA?-1.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-39711000
Enterprise Value?$4.9B
Fundamentals ratios updated end of day